H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 10.4% of adults in Grand Rapids have diagnosed diabetes — 1.6 points below the U.S. 12% figure. Census population 198,917. Michigan Medicare wound biologics: WPS Government Health Administrators (J8). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Grand Rapids clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Grand Rapids storefront.
Chronic Wound Treatment That Works in Grand Rapids, MI for clinics & physicians. Effective chronic wound t… Compliance support & pricing — contact Hawk Medical.
CDC PLACES (2023, crude) estimates 10.4% of adults in Grand Rapids have diagnosed diabetes — 1.6 points below the U.S. 12% figure. Census city-proper population is 198,917. If you are adding chronic wound treatment, start with that epidemiology and with WPS Government Health Administrators (J8) — not with a “near me” clinic listing. Hawk Medical ships nationwide; Joe Bradley’s own practice uses the same product classes.
National Chronic Wound Treatment That Works notes (how the product actually works)CDC PLACES (2023, crude) estimates 10.4% of adults in Grand Rapids have diagnosed diabetes — 1.6 points below the U.S. 12% figure. Adult obesity in Grand Rapids is 36.4% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. Adult arthritis here is 22.6% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Payer geography: J8 / WPS Government Health Administrators, sibling states IN. Michigan Department of Health & Human Services is the public-health home. We will not mash those grains into a fake “demand score.”
We are not going to invent a Grand Rapids warehouse or a five-star local review. What you get is chronic wound treatment from FDA-registered sources, lot paperwork, and someone who has run the same SOPs in clinic — Joe Bradley. The local numbers on this page are CDC PLACES and CMS J8, not marketing adjectives.
CDC PLACES (2023, crude prevalence) estimates 10.4% of adults — 1.6 points below the U.S. 12% figure. Obesity is 36.4%; arthritis is 22.6%. That is place-level BRFSS modeling, not a clinic census and not a Grand Rapids trial.
No. Hawk Medical does not distribute products as “stem cell therapy.” HCT/P 361 allografts are regulated under 21 CFR 1271 for homologous use and minimal manipulation. PRP is autologous. Marketing that blurs those lanes is a compliance problem in every state, including Michigan.
No. PRP (autologous) and cellular/tissue products (allograft/skin substitutes) sit on different coding and coverage paths. WPS Government Health Administrators LCDs for CTPs do not automatically cover PRP injections. Build separate protocols and fee tickets.
This URL is written for healthcare providers shopping distribution. Patient-facing ads must follow your state medical board and FTC rules. Do not copy distributor language into consumer ads that imply guaranteed healing.
If you operate in Michigan and another MAC state, say it on the first call. J8 will not port 1:1. We would rather split utilization than watch a sister clinic copy Grand Rapids tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Grand Rapids, MI.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Grand Rapids is J8 geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Grand Rapids — 1.6 points below the U.S. 12% figure. Planning input, not an outcomes claim.
Michigan Part B wound biologics follow this contractor (siblings: IN). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Grand Rapids. Useful for joint-program math; still needs a diagnosis and privileging.
No Grand Rapids storefront. Joe Bradley is an active practice owner. chronic wound treatment stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.